[
  {
    "title": "Why the Market Dipped But Pfizer (PFE) Gained Today",
    "published": 1713217522,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk",
    "published": 1713197290,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Is Pfizer Stock a Buy?",
    "published": 1713185100,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call",
    "published": 1713181800,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.",
    "published": 1713171180,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "A Closer Look at Pfizer's Options Market Dynamics",
    "published": 1713171060,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M",
    "published": 1713169161,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Morning Brew: Tech Giants Navigate Regulatory Hurdles",
    "published": 1713166260,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)",
    "published": 1713163260,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push",
    "published": 1713156540,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Noteworthy Monday Option Activity: PFE, TOL, OKTA",
    "published": 1713147480,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "Pfizer call volume above normal and directionally bullish",
    "published": 1713144360,
    "posting_price": 24.38178825,
    "close_price": 24.38178825,
    "percent_change": 0.0
  },
  {
    "title": "10 Micro-Cap Healthcare Stocks Insiders Are Buying",
    "published": 1713121228,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Two Brothers, a Big Biotech Bet and an $8 Billion Payout",
    "published": 1713016800,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Big Pharma: Investment Bedrock",
    "published": 1712961000,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Pfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here",
    "published": 1712935833,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Zentalis Pharmaceuticals: Data In 1st Half Of 2024 Could Get The Ball Rolling",
    "published": 1712931143,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News",
    "published": 1712928120,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever",
    "published": 1712916420,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Is Pfizer Stock the Biggest Bargain in the S&P 500?",
    "published": 1712915400,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts say",
    "published": 1712909640,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Biogen Is Suffering From Doubts About the Future",
    "published": 1712908860,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Morning Brew: Tech Giants Lead Market Movements Amid Earnings Anticipation",
    "published": 1712907060,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Healthpeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth",
    "published": 1712905200,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "Pfizer\u2019s Hold Rating Upheld Amid Modest Sales Outperformance and Market Uncertainty",
    "published": 1712896020,
    "posting_price": 24.70173246,
    "close_price": 24.33473587,
    "percent_change": -1.48571195
  },
  {
    "title": "If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names",
    "published": 1712857753,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer: The Market Is Wrong",
    "published": 1712847604,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?",
    "published": 1712841120,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales?",
    "published": 1712841120,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer (NYSE:PFE) Settlement Sends Shares Up Slightly",
    "published": 1712838960,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer unit to settle Effexor XR antitrust claims in $39M deal",
    "published": 1712830680,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25",
    "published": 1712829907,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Interesting PFE Put And Call Options For May 31st",
    "published": 1712828400,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Alkermes' Innovations Are Transforming Mental Health Treatments",
    "published": 1712822460,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Notable open interest changes for April 11th",
    "published": 1712822160,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Morning Brew: Tesla's New Model Sparks Investor Interest",
    "published": 1712822100,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "Parnassus Value Equity Fund's Strategic Moves: Spotlight on Amdocs Ltd with a -1.7% Impact",
    "published": 1712808120,
    "posting_price": 24.79583504,
    "close_price": 24.78642464,
    "percent_change": -0.03795153
  },
  {
    "title": "7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape",
    "published": 1712769738,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "The Pharmaceutical Industry Finds Itself At A Historical Crossroads",
    "published": 1712767671,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Pfizer's (PFE) RSV Vaccine Study in Adults Under 60 Meets Goal",
    "published": 1712755560,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "ClearBridge Appreciation Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712753700,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Pfizer (PFE) Receives a Hold from Berenberg Bank",
    "published": 1712747700,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO in Adults Aged 18 to 59 at Increased Risk for RSV Disease",
    "published": 1712744083,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and Fusion Pharmaceuticals (FUSN)",
    "published": 1712730660,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Where Will Pfizer Stock Be in 10 Years?",
    "published": 1712729160,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "PM Fumio Kishida Urges US Tech Giants To Invest In Japan: 'I'm Strongly Promoting Policies Toward The Next Economic Stage'",
    "published": 1712723340,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Pfizer\u2019s Hold Rating Balances Vaccine Growth Potential with Competitive and Financial Challenges",
    "published": 1712721480,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says",
    "published": 1712713620,
    "posting_price": 24.95580923,
    "close_price": 24.76760483,
    "percent_change": -0.75415066
  },
  {
    "title": "Pfizer unveils positive phase 3 trial results for RSV Vaccine",
    "published": 1712697285,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "NEW YORK MARKET CLOSE: Stocks mixed in choppy trade ahead of CPI data",
    "published": 1712679300,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.",
    "published": 1712674440,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer : March Social Media Round-Up\u2014Annual Review, International Women\u2019s Day, and a School of Science Celebration",
    "published": 1712674269,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Tempus Releases New Data at AACR Showcasing Ways to Analyze Multimodal Data to Highlight Potential Therapeutic Routes for HER2- Directed Antibody-Drug Conjugates in Several Tumor Types",
    "published": 1712670803,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV treatment meets targets in trial of adults under age 60",
    "published": 1712670060,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever",
    "published": 1712664900,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer, with new study results, seeks to bring RSV shot to adults aged 18-59",
    "published": 1712664600,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Novo Nordisk: The Moat Won't Last Forever",
    "published": 1712662210,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ Patients",
    "published": 1712661960,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV shot meets goals in trial of high-risk adults under age 60",
    "published": 1712659650,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO\u00ae in Adults Aged 18 to 59 at Increased Risk for RSV Disease",
    "published": 1712659500,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?",
    "published": 1712656200,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Decoding Pfizer's Options Activity: What's the Big Picture?",
    "published": 1712653380,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer: positive results for RSV in adults",
    "published": 1712651018,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer's Abrysvo Hits Key Goals in Adults at Increased RSV Risk",
    "published": 1712646020,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV shot meets key goal in trial of high-risk adults under age 60",
    "published": 1712643900,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Asian Markets Trend Upwards Amid Anticipation for Inflation Data and Federal Reserve's Next Move",
    "published": 1712643480,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer's Abrysvo meets primary Phase 3 endpoint in RSV disease",
    "published": 1712641860,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth",
    "published": 1712641773,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "3 Dirt-Cheap Stocks That Could Make You Filthy Rich",
    "published": 1712639940,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Election Year Encore: Can 2020\u2019s Top 7 Stock Winners Repeat Their Performance in 2024?",
    "published": 1712633820,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "20 Most Populated Counties in the US",
    "published": 1712613441,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Pfizer (PFE) Declines More Than Market: Some Information for Investors",
    "published": 1712612720,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Is Trending Stock Pfizer Inc. (PFE) a Buy Now?",
    "published": 1712581217,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "GSK, Pfizer-backed ViiV gets FDA okay for HIV drug for adolescents",
    "published": 1712575080,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Why Is Ocugen (OCGN) Stock Up 7% Today?",
    "published": 1712570460,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market",
    "published": 1712569620,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead",
    "published": 1712567160,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV",
    "published": 1712564580,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Notable open interest changes for April 8th",
    "published": 1712562960,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'",
    "published": 1712562060,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "ViiV Healthcare announces FDA approval of Dovato for adolescents with HIV",
    "published": 1712560440,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "The 3 Most Undervalued Healthcare Stocks to Buy in April 2024",
    "published": 1712559960,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stocks",
    "published": 1712493540,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stock performance",
    "published": 1712493180,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "My Top-5 Ultrahigh-Yield Dividend Stocks to Buy in April",
    "published": 1712483220,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst",
    "published": 1712473500,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Jury sides with SEC in trial over insider trading charges against former pharma executive",
    "published": 1712401200,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "The 3 Most Undervalued Biotech Stocks to Buy in April 2024",
    "published": 1712321820,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Pfizer's Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study",
    "published": 1712320380,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Pfizer (PFE), Eli Lilly & Co (LLY)",
    "published": 1712316060,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income",
    "published": 1712311920,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Working to \u201cOutdo\u201d Cancer: A Multi-Modality Approach to Accelerating the Next Generation of Cancer Breakthroughs",
    "published": 1712309887,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Pfizer Inc. stock rises Friday, still underperforms market",
    "published": 1712288700,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024",
    "published": 1712288220,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "3 Healthcare Stocks Short Sellers Are Prescribing for Trouble",
    "published": 1712281200,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster",
    "published": 1712218980,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "Viatris- Theramex deal for women's care products raises antitrust concerns in U.K.",
    "published": 1712217600,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "CCI, PFE: 2 High-Yield Dividend Stocks to Buy, According to Analysts",
    "published": 1712213100,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "Sanofi to Resolve 4,000 Zantac Cancer Lawsuits in US Courts",
    "published": 1712209440,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.",
    "published": 1712206800,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "published": 1712149209,
    "posting_price": 25.88741723,
    "close_price": 25.61452103,
    "percent_change": -1.05416542
  },
  {
    "title": "Jefferies sees Roivant rallying 5%-10% on today's COVID patent order",
    "published": 1712149020,
    "posting_price": 25.88741723,
    "close_price": 25.61452103,
    "percent_change": -1.05416542
  },
  {
    "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "published": 1712062812,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April",
    "published": 1712049660,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era",
    "published": 1712049480,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race",
    "published": 1712022900,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "Pfizer\u2019s Earnings Are Due. Questions About the Company\u2019s Outlook Linger.",
    "published": 1714509000,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?",
    "published": 1714492680,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?",
    "published": 1714490400,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Pfizer and Genmab\u2019s Tivdak wins full FDA approval for cervical cancer",
    "published": 1714485726,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Pfizer : Goes Live in SXSW\u2019s Podcast Lounge",
    "published": 1714482554,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "7 Safe Haven Stocks That Can Withstand the Market\u2019s Worst Meltdowns",
    "published": 1714481520,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Eli Lilly (LLY) Tops Q1 Earnings Estimates",
    "published": 1714478105,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "5 Top Stocks to Buy in May",
    "published": 1714477500,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "FDA approves Labcorp companion diagnostic for Pfizer gene therapy",
    "published": 1714476124,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response",
    "published": 1714473000,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings",
    "published": 1714472700,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "(PFE) - Analyzing Pfizer's Short Interest",
    "published": 1714470600,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist",
    "published": 1714470600,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "FTC expands patent listing challenges for drugs",
    "published": 1714468440,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead",
    "published": 1714467960,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations",
    "published": 1714467180,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Sensodyne maker Haleon to shut UK factory with loss of 435 jobs",
    "published": 1714467060,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Morning Brew: Tech Giants Lead Market Movements Amidst Earnings Season",
    "published": 1714462260,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound",
    "published": 1714456800,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Pfizer, Genmab cervical cancer therapy wins full FDA approval",
    "published": 1714455000,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Longboard initiated with an Outperform at Baird on 'best-in-class potential",
    "published": 1714446660,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "Pfizer Q1 Earnings Preview: Covid assets to remain the focus this quarter",
    "published": 1714439280,
    "posting_price": 24.13712184,
    "close_price": 24.10889244,
    "percent_change": -0.11695429
  },
  {
    "title": "FDA Grants Full Approval for TIVDAK\u00ae to Treat Recurrent or Metastatic Cervical Cancer",
    "published": 1714430400,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "UPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drug",
    "published": 1714423874,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1?",
    "published": 1714413175,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings",
    "published": 1714407120,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "mRNA Is Promising A Breakthrough In Fighting Cancer",
    "published": 1714406563,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "US FDA grants full approval for Pfizer's cervical cancer drug",
    "published": 1714406302,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Why Pfizer (PFE) is a Top Value Stock for the Long-Term",
    "published": 1714398009,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Novel haemophilia B gene therapy approved",
    "published": 1714390270,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting",
    "published": 1714387500,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Merck late-stage data strengthens profile of pneumonia vaccine candidate",
    "published": 1714382580,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Novo Nordisk: Growth Is Still A Better Choice",
    "published": 1714377660,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Pfizer, Genmab get full FDA approval for cervical-cancer drug",
    "published": 1714373820,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Pfizer (PFE) Gets a Buy from Truist Financial",
    "published": 1714373640,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Labcorp\u2019s companion diagnostic approved for use with Pfizer\u2019s hemophilia B gene therapy",
    "published": 1714372500,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Labcorp: FDA approves nAbCyte Anti-AAVRh74var HB-FE Assay",
    "published": 1714370640,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Genmab-Pfizer gain full FDA approval for TIVDAK in Metastatic Cervical Cancer",
    "published": 1714369440,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "Genmab-Pfizer's gains full FDA approval for TIVDAK in Metastatic Cervical Cancer",
    "published": 1714369380,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "3 Dividend Stocks to Buy on the Dip: April 2024",
    "published": 1714366920,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street",
    "published": 1714297800,
    "posting_price": 24.07124974,
    "close_price": 24.12771034,
    "percent_change": 0.23455616
  },
  {
    "title": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "published": 1714216500,
    "posting_price": 24.07125165,
    "close_price": 24.12771225,
    "percent_change": 0.23455615
  },
  {
    "title": "WHO picks JN.1 variant for next set of COVID vaccines",
    "published": 1714180440,
    "posting_price": 24.07125165,
    "close_price": 24.12771225,
    "percent_change": 0.23455615
  },
  {
    "title": "A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed",
    "published": 1714169837,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia",
    "published": 1714163408,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "S&P 500 Earnings: The Upward Revisions Are A Big Positive",
    "published": 1714161600,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Sector Update: Health Care Stocks Edge Higher Late Afternoon",
    "published": 1714161434,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer Gets FDA Approval for Bleeding Disorder Treatment",
    "published": 1714152249,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Diving Into Deciphera Pharmaceuticals",
    "published": 1714147000,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer Receives FDA Approval for Bleeding Disorder Treatment",
    "published": 1714140840,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics",
    "published": 1714137323,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure",
    "published": 1714136045,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates",
    "published": 1714135502,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "AbbVie's Q1: Positive Surprise",
    "published": 1714132910,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks",
    "published": 1714131900,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer gets FDA approval for hemophilia B gene therapy Beqvez",
    "published": 1714131840,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer (NYSE:PFE) Notches Up on New FDA Approval",
    "published": 1714131240,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "US approves Pfizer gene therapy treatment for haemophilia",
    "published": 1714131120,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer gets FDA approve for hemophilia B gene therapy",
    "published": 1714129440,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "UPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorder",
    "published": 1714129219,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer hemophilia gene therapy arrives in US to uncertain future",
    "published": 1714128780,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "U.S. FDA Approves Pfizer\u2019s BEQVEZ\u2122 (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B",
    "published": 1714128300,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "June 7th Options Now Available For Pfizer (PFE)",
    "published": 1714126320,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer's Options: A Look at What the Big Money is Thinking",
    "published": 1714122300,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Should You Buy Moderna Before May 12?",
    "published": 1714121400,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B",
    "published": 1714115725,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Pfizer announces approval of BEQVE by FDA for adults with hemophilia B",
    "published": 1714110480,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle",
    "published": 1714096200,
    "posting_price": 23.83599591,
    "close_price": 23.90186691,
    "percent_change": 0.27635095
  },
  {
    "title": "Wall Street plunges after US inflation shock",
    "published": 1714066104,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines",
    "published": 1714064153,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma",
    "published": 1714059724,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology",
    "published": 1714053265,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology",
    "published": 1714052384,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "What's Going On With Pfizer Stock On Thursday?",
    "published": 1714049700,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Video: Daily Dividend Report: PFE, SCHW, CI, MPC, AVY",
    "published": 1714049100,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "GSK sues Pfizer, BioNTech over COVID-19 vaccines patents",
    "published": 1714039260,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Dividend Harvesting Portfolio Week 164: $16,400 Allocated, $1,466.94 In Projected Dividends",
    "published": 1714035600,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Morning Brew: Tech Titans Lead Market Movements Amid Key Updates",
    "published": 1714030260,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Bristol-Myers posts Q1 beat despite growth headwinds",
    "published": 1714028460,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "UPDATE 1-Ad group WPP reports 1.6% drop in first-quarter organic growth",
    "published": 1714026417,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Pantera Minerals Expands Lithium Project and Secures Funding",
    "published": 1714024680,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
    "published": 1714016400,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "RSI Alert: Pfizer Now Oversold",
    "published": 1714013700,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Takeda said to have left industry trade group BIO",
    "published": 1714012740,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Noteworthy Thursday Option Activity: PFE, ON, PTON",
    "published": 1714011540,
    "posting_price": 24.7205552,
    "close_price": 23.77012634,
    "percent_change": -3.84469059
  },
  {
    "title": "Pfizer Declares Second-Quarter 2024 Dividend",
    "published": 1713991020,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?",
    "published": 1713974700,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "Pfizer : Political Action Committee (PAC) Report",
    "published": 1713973568,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for",
    "published": 1713967314,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "Morning Brew: Tesla's Innovative Moves Spark Market Interest",
    "published": 1713943920,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth",
    "published": 1713940260,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "March Readers Marked 20 Ideal-To-Buy Dividend Dogs",
    "published": 1713938963,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains",
    "published": 1713937140,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "Second Circuit Rules That Associational Standing For A Preliminary Injunction Requires Identifying At Least One Injured Member By Name",
    "published": 1713931932,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "Pfizer declares $0.42 dividend",
    "published": 1713930120,
    "posting_price": 24.70173546,
    "close_price": 24.72055626,
    "percent_change": 0.07619222
  },
  {
    "title": "Better Buy: Pfizer vs. Viking Therapeutics",
    "published": 1713878100,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "Pfizer vs Moderna battle over COVID vaccine patents begins in UK",
    "published": 1713871281,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "European Commission Approves Pfizer's EMBLAVEO for Patients with Multidrug-Resistant Infections and Limited Treatment Options",
    "published": 1713866783,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "Edgewise gets EU orphan drug status for muscular dystrophy drug",
    "published": 1713865020,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "Baron Health Care Fund Q1 2024 Shareholder Letter",
    "published": 1713864600,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "Takeda Pharmaceutical: A Long-Term Cash Cow",
    "published": 1713859260,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)",
    "published": 1713846780,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "US Stock: Pfizer",
    "published": 1713843600,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge",
    "published": 1713837780,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "Moderna, Pfizer/BioNTech set for UK court clash over Covid jab patents",
    "published": 1713835620,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "3 Defensive Stocks To Protect Your Portfolio In 2024",
    "published": 1713834480,
    "posting_price": 24.77701714,
    "close_price": 24.76760674,
    "percent_change": -0.03798036
  },
  {
    "title": "Pfizer (PFE) Rises Higher Than Market: Key Facts",
    "published": 1713822320,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "European Commission approves novel antibiotic",
    "published": 1713794467,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "European Commission Approves Pfizer\u2019s EMBLAVEO\u00ae for Patients with Multidrug-Resistant Infections and Limited Treatment Options",
    "published": 1713787680,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "Sanofi reportedly settles 4K Zantac cases for $100M",
    "published": 1713784320,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "Pfizer Options Trading: A Deep Dive into Market Sentiment",
    "published": 1713782100,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "Pfizer: new Emblaveo antibiotic approved in the EU",
    "published": 1713780647,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "EU regulators approve Pfizer antibiotic Emblaveo",
    "published": 1713777480,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "Morning Brew: Tech Giants Lead Market Movements Amid Earnings Reports",
    "published": 1713771060,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "Pfizer announces EC approval for Emblaveo",
    "published": 1713770040,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years",
    "published": 1713761340,
    "posting_price": 24.46648038,
    "close_price": 24.7111454,
    "percent_change": 1.00000088
  },
  {
    "title": "11 Best Low Price Pharma Stocks To Invest In",
    "published": 1713710398,
    "posting_price": 24.46647849,
    "close_price": 24.71114349,
    "percent_change": 1.00000088
  },
  {
    "title": "Some Bubbles Are Starting To Pop",
    "published": 1713696558,
    "posting_price": 24.46647849,
    "close_price": 24.71114349,
    "percent_change": 1.00000088
  },
  {
    "title": "High-Quality Dividend Growth Near 52-Week Lows: Apple Is Attractive",
    "published": 1713692167,
    "posting_price": 24.46647849,
    "close_price": 24.71114349,
    "percent_change": 1.00000088
  },
  {
    "title": "3 Stocks Under $50 You Can Buy Hand Over Fist Right Now",
    "published": 1713606600,
    "posting_price": 24.46647849,
    "close_price": 24.71114349,
    "percent_change": 1.00000088
  },
  {
    "title": "Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.",
    "published": 1713598260,
    "posting_price": 24.46647849,
    "close_price": 24.71114349,
    "percent_change": 1.00000088
  },
  {
    "title": "Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock",
    "published": 1713531615,
    "posting_price": 23.89245841,
    "close_price": 24.46648026,
    "percent_change": 2.40252317
  },
  {
    "title": "Morning Brew: Tech Giants Lead Market Movements Amid Key Announcements",
    "published": 1713511920,
    "posting_price": 23.89245841,
    "close_price": 24.46648026,
    "percent_change": 2.40252317
  },
  {
    "title": "Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth",
    "published": 1713510228,
    "posting_price": 23.89245841,
    "close_price": 24.46648026,
    "percent_change": 2.40252317
  },
  {
    "title": "Boost Your Dividend Income With These Two High-Yield Stocks",
    "published": 1713463200,
    "posting_price": 23.85481816,
    "close_price": 23.89245796,
    "percent_change": 0.15778699
  },
  {
    "title": "If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today",
    "published": 1713446100,
    "posting_price": 23.85481816,
    "close_price": 23.89245796,
    "percent_change": 0.15778699
  },
  {
    "title": "December 20th Options Now Available For Pfizer (PFE)",
    "published": 1713433080,
    "posting_price": 23.85481816,
    "close_price": 23.89245796,
    "percent_change": 0.15778699
  },
  {
    "title": "Dividend Harvesting Portfolio Week 163: $16,300 Allocated, $1,458.36 In Projected Dividends",
    "published": 1713430800,
    "posting_price": 23.85481816,
    "close_price": 23.89245796,
    "percent_change": 0.15778699
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Pfizer",
    "published": 1713429120,
    "posting_price": 23.85481816,
    "close_price": 23.89245796,
    "percent_change": 0.15778699
  },
  {
    "title": "ClearBridge Appreciation ESG Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1713427200,
    "posting_price": 23.85481816,
    "close_price": 23.89245796,
    "percent_change": 0.15778699
  },
  {
    "title": "Johnson & Johnson: Buy This Bargain Before It's Gone",
    "published": 1713425319,
    "posting_price": 23.85481816,
    "close_price": 23.89245796,
    "percent_change": 0.15778699
  },
  {
    "title": "The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback",
    "published": 1713390535,
    "posting_price": 24.17476211,
    "close_price": 23.92068672,
    "percent_change": -1.05099438
  },
  {
    "title": "Pfizer-Connect Biopharma deal for anti-inflammatory agent ends",
    "published": 1713357000,
    "posting_price": 24.17476211,
    "close_price": 23.92068672,
    "percent_change": -1.05099438
  },
  {
    "title": "Canaan hires Pfizer executive, reels in $100M for biotech investing",
    "published": 1713348000,
    "posting_price": 24.17476211,
    "close_price": 23.92068672,
    "percent_change": -1.05099438
  },
  {
    "title": "CVS favors Humira copycats hurting AbbVie\u2019s market share: Evercore",
    "published": 1713342720,
    "posting_price": 24.17476211,
    "close_price": 23.92068672,
    "percent_change": -1.05099438
  },
  {
    "title": "Morning Brew: Tech Giants Rally Amid Market Optimism",
    "published": 1713339120,
    "posting_price": 24.17476211,
    "close_price": 23.92068672,
    "percent_change": -1.05099438
  },
  {
    "title": "Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff",
    "published": 1713289757,
    "posting_price": 24.29709624,
    "close_price": 24.17476463,
    "percent_change": -0.50348243
  },
  {
    "title": "As more rare disease therapies launch, their prices are rising",
    "published": 1713266880,
    "posting_price": 24.29709624,
    "close_price": 24.17476463,
    "percent_change": -0.50348243
  },
  {
    "title": "Pantera Minerals Seeks Quotation for New Shares",
    "published": 1713265080,
    "posting_price": 24.29709624,
    "close_price": 24.17476463,
    "percent_change": -0.50348243
  },
  {
    "title": "Pantera Minerals Expands Lithium Project Acreage",
    "published": 1713254280,
    "posting_price": 24.29709624,
    "close_price": 24.17476463,
    "percent_change": -0.50348243
  }
]